These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9310488)

  • 1. Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy.
    Ross C; Svenson M; Nielsen H; Lundsgaard C; Hansen MB; Bendtzen K
    Blood; 1997 Sep; 90(6):2376-80. PubMed ID: 9310488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations.
    Wadhwa M; Meager A; Dilger P; Bird C; Dolman C; Das RG; Thorpe R
    Immunology; 2000 Jan; 99(1):113-23. PubMed ID: 10651949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid, accurate and robust particle-based assay for the simultaneous screening of plasma samples for the presence of five different anti-cytokine autoantibodies.
    Guldager DKR; von Stemann JH; Larsen R; Bay JT; Galle PS; Svenson M; Ullum H; Hansen MB
    J Immunol Methods; 2015 Oct; 425():62-68. PubMed ID: 26080061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.
    Svenson M; Hansen MB; Ross C; Diamant M; Rieneck K; Nielsen H; Bendtzen K
    Blood; 1998 Mar; 91(6):2054-61. PubMed ID: 9490690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
    Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
    J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of cytokines to pharmaceutically prepared human immunoglobulin.
    Svenson M; Hansen MB; Bendtzen K
    J Clin Invest; 1993 Nov; 92(5):2533-9. PubMed ID: 8227366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response.
    Tomer Y; Barak V; Gilburd B; Shoenfeld Y
    Clin Exp Rheumatol; 1999; 17(5):521-6. PubMed ID: 10544833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interleukin-6 antibodies in normal human serum.
    Hansen MB; Svenson M; Diamant M; Bendtzen K
    Scand J Immunol; 1991 Jun; 33(6):777-81. PubMed ID: 2047765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of proinflammatory cytokines on Actinobacillus actinomycetemcomitans specific IgG responses.
    Tanaka S; Fakher M; Barbour SE; Schenkein HA; Tew JG
    J Periodontal Res; 2006 Feb; 41(1):1-9. PubMed ID: 16409249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Anticytokine Autoantibody Levels Are Not Increased in Hidradenitis Suppurativa: A Case-Control Pilot Study.
    Theut Riis P; von Stemann JH; Kjærsgaard Andersen R; Hansen MB; Jemec GBE
    Dermatology; 2017; 233(2-3):126-128. PubMed ID: 28675899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
    Aydinoglu-Candan Ö; Araz-Erşan B; Gul A; Badur S; Tugal-Tutkun I
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):457-65. PubMed ID: 25500983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice.
    Boelen A; Platvoet-ter Schiphorst MC; Wiersinga WM
    J Endocrinol; 1997 Apr; 153(1):115-22. PubMed ID: 9135576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a.
    Ross C; Engler CB; Sander B; Bendtzen K
    J Interferon Cytokine Res; 2002 Apr; 22(4):421-6. PubMed ID: 12034024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 mediated isotype specific suppression of hapten specific IgE in serum of BPO-KLH sensitized mice: role of IFN alpha in maintainance of hapten specific IgE responses.
    Auci DL; Miller H; Chice SM; Durkin HG
    Immunol Invest; 1994 Apr; 23(3):213-21. PubMed ID: 8070849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.
    Issekutz AC; Rowter D; Miescher S; Käsermann F
    Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of high-affinity anti-IL-1 alpha autoantibodies in normal human serum as an interfering substance in a sensitive enzyme-linked immunosorbent assay for IL-1 alpha.
    Mae N; Liberato DJ; Chizzonite R; Satoh H
    Lymphokine Cytokine Res; 1991 Apr; 10(1-2):61-8. PubMed ID: 1831388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition--higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia).
    Saurat JH; Schifferli J; Steiger G; Dayer JM; Didierjean L
    J Allergy Clin Immunol; 1991 Aug; 88(2):244-56. PubMed ID: 1831824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera.
    Svenson M; Bagge Hansen M; Bendtzen K
    Scand J Immunol; 1990 Dec; 32(6):695-701. PubMed ID: 2270440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.
    Hempel G; Galle PR; Löhr HF
    J Med Virol; 2001 Jul; 64(3):340-9. PubMed ID: 11424124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.